CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

CA Cancer J Clin 2006; 56:37-47
doi: 10.3322/canjclin.56.1.37
© 2006 American Cancer Society
This Article
Right arrow Full Text Freely available
Right arrow Full Text (PDF) Freely available
Right arrow Freely available CME: Take the course for this article:
 Breast Cancer Staging
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singletary, S. E.
Right arrow Articles by Connolly, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singletary, S. E.
Right arrow Articles by Connolly, J. L.

Breast Cancer Staging: Working With the Sixth Edition of the AJCC Cancer Staging Manual

S. Eva Singletary, MD, FACS and James L. Connolly, MD


Dr. Singletary is Professor, Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX.
Dr. Connolly is Director of Anatomic Pathology, Department of Pathology, Harvard Medical School/Beth Israel Deaconess Medical Center, Boston, MA.

The sixth edition of the AJCC Cancer Staging Manual contains some of the most extensive and significant revisions that have ever been made in the breast cancer staging system. The principal changes are related to the size, number, location, and method of detection of regional metastases to the lymph nodes. Some changes are related to the growing use of new technology (eg, sentinel lymph node biopsy, immunohistochemical staining, reverse transcriptase-polymerase chain reaction), whereas others are amendments of prior staging criteria, reflecting recent clinical evidence or widespread clinical consensus. Available data did not support the addition of new prognostic indicators such as histologic tumor grade to the tumor-node-metastasis system at this time. Future developments in determining breast cancer prognosis will most likely incorporate new approaches to identifying the genetic fingerprint of individual tumors.




This article has been cited by other articles:


Home page
 Ann. Surg. Oncol.Home page
A. M. Fink, H. Lass, H. Hartleb, W. Jurecka, H. Salzer, and A. Steiner
S-Classification of Sentinel Lymph Node Predicts Axillary Nonsentinel Lymph Node Status in Patients with Breast Cancer
Ann. Surg. Oncol., March 1, 2008; 15(3): 848 - 853.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
J. H. Chen, G. Agrawal, P. Carpenter, R. S. Mehta, O. Nalcioglu, and M.-Y. Su
Pathological Axillary Lymph Node Status in HER-2 Receptor Positive and Negative Breast Cancers
Ann. Surg. Oncol., March 1, 2008; 15(3): 941 - 942.
[Full Text] [PDF]

Home page
 JCOHome page
E. J.T. Rutgers
Sentinel Node Biopsy: Interpretation and Management of Patients With Immunohistochemistry-Positive Sentinel Nodes and Those With Micrometastases
J. Clin. Oncol., February 10, 2008; 26(5): 698 - 702.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
C. F. Levenback
Status of Sentinel Lymph Node Biopsy in Gynecological Cancers
Ann. Surg. Oncol., January 1, 2008; 15(1): 18 - 20.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Decock, J.-R. Long, R. C. Laxton, X.-O. Shu, C. Hodgkinson, W. Hendrickx, E. G. Pearce, Y.-T. Gao, A. C. Pereira, R. Paridaens, et al.
Association of Matrix Metalloproteinase-8 Gene Variation with Breast Cancer Prognosis
Cancer Res., November 1, 2007; 67(21): 10214 - 10221.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Nakagawa, S. R. Martinez, Y. Goto, K. Koyanagi, M. Kitago, T. Shingai, D. A. Elashoff, X. Ye, F. R. Singer, A. E. Giuliano, et al.
Detection of Circulating Tumor Cells in Early-Stage Breast Cancer Metastasis to Axillary Lymph Nodes
Clin. Cancer Res., July 15, 2007; 13(14): 4105 - 4110.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
D. P. Cronin-Fenton, L. A. Ries, L. X. Clegg, and B. K. Edwards
Rising Incidence Rates of Breast Carcinoma With Micrometastatic Lymph Node Involvement
J Natl Cancer Inst, July 4, 2007; 99(13): 1044 - 1049.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Esseghir, A. Kennedy, P. Seedhar, A. Nerurkar, R. Poulsom, J. S. Reis-Filho, and C. M. Isacke
Identification of NTN4, TRA1, and STC2 as Prognostic Markers in Breast Cancer in a Screen for Signal Sequence Encoding Proteins
Clin. Cancer Res., June 1, 2007; 13(11): 3164 - 3173.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. Mocellin, D. S.B. Hoon, P. Pilati, C. R. Rossi, and D. Nitti
Sentinel Lymph Node Molecular Ultrastaging in Patients With Melanoma: A Systematic Review and Meta-Analysis of Prognosis
J. Clin. Oncol., April 20, 2007; 25(12): 1588 - 1595.
[Abstract] [Full Text] [PDF]

Home page
 CA Cancer J ClinHome page
S. L. Chen, D. M. Iddings, R. P. Scheri, and A. J. Bilchik
Lymphatic Mapping and Sentinel Node Analysis: Current Concepts and Applications
CA Cancer J Clin, September 1, 2006; 56(5): 292 - 309.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by American Cancer Society.